Alpha-methylated tryptamine derivatives induce a 5-HT receptor-mediated head-twitch response in mice

[1]  S. Kim,et al.  Inhibition of monoamine oxidase by two substrate-analogues, with different preferences for 5-hydroxytryptamine neurons , 1991, Neuropharmacology.

[2]  N. Satoh,et al.  Inhibition of Brain Type A Monoamine Oxidase and 5‐Hydroxytryptamine Uptake by Two Amphetamine Metabolites, p‐Hydroxyamphetamine and p‐Hydroxynorephedrine , 1990, Journal of neurochemistry.

[3]  N. Satoh,et al.  Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. , 1989, The Journal of pharmacology and experimental therapeutics.

[4]  H. Saito,et al.  Rapid Determination of Norepinephrine, Dopamine, Serotonin, Their Precursor Amino Acids, and Related Metabolites in Discrete Brain Areas of Mice Within Ten Minutes by HPLC with Electrochemical Detection , 1988, Journal of neurochemistry.

[5]  H. Kinemuchi,et al.  Selective inhibition of monoamine oxidase A and B by two substrate-analogues, 5-fluoro-alpha-methyltryptamine and p-chloro-beta-methylphenethylamine. , 1986, Research communications in chemical pathology and pharmacology.

[6]  H. Kinemuchi,et al.  Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Relationship between the enzyme inhibition and the neurotoxicity , 1985, Neuroscience Letters.

[7]  C. Fowler,et al.  Selective inhibitors of monoamine oxidase A and B: Biochemical, pharmacological, and clinical properties , 1984, Medicinal research reviews.

[8]  K. Tipton,et al.  On the substrate specificities of the two forms of monoamine oxidase , 1984, The Journal of pharmacy and pharmacology.

[9]  K. Tipton,et al.  Inhibition of monoamine oxidase by amphetamine and related compounds. , 1976, Biochemical pharmacology.

[10]  W. Taylor,et al.  Effects of amphetamine and its hydroxylated metabolites on central noradrenergic mechanisms. , 1973, The Journal of pharmacology and experimental therapeutics.

[11]  S. Handley,et al.  Temperature changes produced by the injection of catecholamines and 5‐hydroxytryptamine into the cerebral ventricles of the conscious mouse , 1967, The Journal of physiology.

[12]  S. Corne,et al.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. , 1963, British journal of pharmacology and chemotherapy.

[13]  H. Kinemuchi,et al.  Studies on 5-fluoro-alpha-methyltryptamine and p-chloro-beta-methylphenethylamine: determination of the MAO-A or MAO-B selective inhibition in vitro. , 1988, Japanese journal of pharmacology.

[14]  H. Kinemuchi,et al.  Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. II. Inhibition by alpha-methylated substrate-analogue monoamines, alpha-methyltryptamine, alpha-methylbenzylamine and two enantiomers of alpha-methylbenzylamine. , 1986, Japanese journal of pharmacology.

[15]  I. Lucki,et al.  Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.